Photobiomodulation Therapy Market by Application - Global Industry Analysis & Forecast to 2027

Published On : September 2019 Pages : 147 Category: Biotechnology Report Code : HC095646

Photobiomodulation Therapy Market By Application (Pain Management, Musculoskeletal, Arthritis, Wound Healing, Dermatology, Nerve regeneration and Others) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Photobiomodulation Therapy Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Photobiomodulation Therapy otherwise called low level laser treatment (LLLT) lessens torment, improves wound mending, recovers nerves and remembers muscle pressure. The Photobiomodulation Therapy offers every one of these advances over pharmaceuticals and the related symptoms.

Drivers and Restraints

Photobiomodulation Therapy has built up a great deal of utilizations in the field of human services. The clinical use of laser treatment in the field of social insurance is as of now phenomenal. Photobiomodulation Therapy has effectively demonstrated it productivity in ligament strains, incessant back agony, mouth blisters, consumes and strokes and are utilized consistently in numerous centers. In addition, the expanding predominance pace of malignant growth has additionally made cold laser treatment another treatment choice in the field of clinical research.

Regional Insights

Asia Pacific is the quickest developing district as chilly Photobiomodulation Therapy is yet to be investigated in this locale. There are number of research undertaking and more up to date revelations of the benefits of light treatment.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • BioLight Technologies LLC
  • THOR
  • LumiThera
  • Vielight Inc.
  • Aspen Laser Systems, LLC,
  • Theralase Inc
  • Apira Science Inc.
  • IRRADIA AUSTRALIA
  • Good Health Tech.
  • Omega Laser Systems Ltd

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Photobiomodulation Therapy Market, By Application, Estimates and Forecast, 2017-2027 ($Million)

o   Pain Management

o   Musculoskeletal

o   Arthritis

o   Wound Healing

o   Dermatology

o   Nerve Regeneration

o   Others

o   Photobiomodulation Therapy Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)

o   BioLight Technologies LLC

o   THOR

o   LumiThera

o   Vielight Inc.

o   Aspen Laser Systems, LLC,

o   Theralase Inc

o   Apira Science Inc.

o   IRRADIA AUSTRALIA

o   Good Health Tech.

o   Omega Laser Systems Ltd

o   Photobiomodulation Therapy Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o   North America

§  North America Photobiomodulation Therapy Market, By Country

o   U.S. Photobiomodulation Therapy Market

o   Canada Photobiomodulation Therapy Market

o   Mexico Photobiomodulation Therapy Market

o   Europe

§  Europe Photobiomodulation Therapy Market, By Country

o   Germany Photobiomodulation Therapy Market

o   UK Photobiomodulation Therapy Market

o   France Photobiomodulation Therapy Market

o   Russia Photobiomodulation Therapy Market

o   Italy Photobiomodulation Therapy Market

o   Rest of Europe Photobiomodulation Therapy Market

o   Asia-Pacific

§  Asia-Pacific Photobiomodulation Therapy Market, By Country

o   China Photobiomodulation Therapy Market

o   Japan Photobiomodulation Therapy Market

o   South Korea  Photobiomodulation Therapy Market

o   India Photobiomodulation Therapy Market

o   Southeast Asia Photobiomodulation Therapy Market

o   Rest of Asia-Pacific Photobiomodulation Therapy Market

o   South America

§  South America Photobiomodulation Therapy Market, By Country

o   Brazil Photobiomodulation Therapy Market

o   Argentina Photobiomodulation Therapy Market

o   Columbia Photobiomodulation Therapy Market

o   Rest of South America Photobiomodulation Therapy Market

o   Middle East and Africa

§  Middle East and Africa Photobiomodulation Therapy Market, By Country

o   Saudi Arabia Photobiomodulation Therapy Market

o   UAE Photobiomodulation Therapy Market

o   Egypt Photobiomodulation Therapy Market

o   Nigeria Photobiomodulation Therapy Market

o   South Africa Photobiomodulation Therapy Market

o   Rest of MEA Photobiomodulation Therapy Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2017-2027)

4.1.2.  Canada Market Status and Outlook (2017-2027)

4.1.3.  Mexico Market Status and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2017-2027)

4.2.2.  France Market Status and Outlook (2017-2027)

4.2.3.  UK Market Status and Outlook (2017-2027)

4.2.4.  Russia Market Status and Outlook (2017-2027)

4.2.5.  Italy Market Status and Outlook (2017-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2017-2027)

4.3.2.  Japan Market Status and Outlook (2017-2027)

4.3.3.  Korea Market Status and Outlook (2017-2027)

4.3.4.  India Market Status and Outlook (2017-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2017-2027)

4.4.2.  Argentina Market Status and Outlook (2017-2027)

4.4.3.  Columbia Market Status and Outlook (2017-2027)

4.4.4.  Rest of South America Market Status and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3.  Egypt Market Status and Outlook (2017-2027)

4.5.4.  Nigeria Market Status and Outlook (2017-2027)

4.5.5.  South Africa Market Status and Outlook (2017-2027)

4.5.6.  Turkey Market Status and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5.       Photobiomodulation Therapy Market, By Application

5.1.     Introduction

5.2.     Global Photobiomodulation Therapy Revenue and Market Share by Application (2017-2027)

5.2.1.  Global Photobiomodulation Therapy Revenue and Revenue Share by Application (2017-2027)

5.3.     Pain Management

5.3.1.  Global Pain Management Revenue and Growth Rate (2017-2027)

5.4.     Musculoskeletal

5.4.1.  Global Musculoskeletal Revenue and Growth Rate (2017-2027)

5.5.     Arthritis

5.5.1.  Global Arthritis Revenue and Growth Rate (2017-2027)

5.6.     Wound Healing

5.6.1.  Global Wound Healing Revenue and Growth Rate (2017-2027)

5.7.     Dermatology

5.7.1.  Global Dermatology Revenue and Growth Rate (2017-2027)

5.8.     Nerve Regeneration

5.8.1.  Global Nerve Regeneration Revenue and Growth Rate (2017-2027)

5.9.     Others

5.9.1.  Global Others Revenue and Growth Rate (2017-2027)

6.       Photobiomodulation Therapy Market, By Region

6.1.     Introduction

6.2.     Global Photobiomodulation Therapy Revenue and Market Share by Regions

6.2.1.  Global Photobiomodulation Therapy Revenue by Regions (2017-2027)

6.3.     North America Photobiomodulation Therapy by Countries

6.3.1.  North America Photobiomodulation Therapy Revenue and Growth Rate (2017-2027)

6.3.2.  North America Photobiomodulation Therapy Revenue (Million USD) by Countries (2017-2027)

6.3.3.  United States

6.3.3.1.  United States Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.3.4.  Canada

6.3.4.1.  Canada Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.3.5.  Mexico

6.3.5.1.  Mexico Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.     Europe Photobiomodulation Therapy by Countries

6.4.1.  Europe Photobiomodulation Therapy Revenue and Growth Rate (2017-2027)

6.4.2.  Europe Photobiomodulation Therapy Revenue (Million USD) by Countries (2017-2027)

6.4.3.  Germany

6.4.3.1.  Germany Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.4.  France

6.4.4.1.  France Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.5.  UK

6.4.5.1.  UK Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.6.  Russia

6.4.6.1.  Russia Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.7.  Italy

6.4.7.1.  Italy Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.4.8.  Rest of Europe

6.4.8.1.  Rest of Europe Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.     Asia-Pacific Photobiomodulation Therapy by Countries

6.5.1.  Asia-Pacific Photobiomodulation Therapy Revenue and Growth Rate (2017-2027)

6.5.2.  Asia-Pacific Photobiomodulation Therapy Revenue (Million USD) by Countries (2017-2027)

6.5.3.  China

6.5.3.1.  China Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.4.  Japan

6.5.4.1.  Japan Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.5.  Korea

6.5.5.1.  Korea Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.6.  India

6.5.6.1.  India Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.7.  Southeast Asia

6.5.7.1.  Southeast Asia Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.5.8.  Rest of Asia-Pacific

6.5.8.1.  Rest of Asia-Pacific Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.     South America Photobiomodulation Therapy by Countries

6.6.1.  South America Photobiomodulation Therapy Revenue and Growth Rate (2017-2027)

6.6.2.  South America Photobiomodulation Therapy Revenue (Million USD) by Countries (2017-2027)

6.6.3.  Brazil

6.6.3.1.  Brazil Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.4.  Argentina

6.6.4.1.  Argentina Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.5.  Columbia

6.6.5.1.  Columbia Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.6.6.  Rest of South America

6.6.6.1.  Rest of South America Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.     Middle East and Africa Photobiomodulation Therapy by Countries

6.7.1.  Middle East and Africa Photobiomodulation Therapy Revenue and Growth Rate (2017-2027)

6.7.2.  Middle East and Africa Photobiomodulation Therapy Revenue (Million USD) by Countries (2017-2027)

6.7.3.  Saudi Arabia

6.7.3.1.  Saudi Arabia Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.4.  United Arab Emirates

6.7.4.1.  United Arab Emirates Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.5.  Egypt

6.7.5.1.  Egypt Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.6.  Nigeria

6.7.6.1.  Nigeria Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.7.  South Africa

6.7.7.1.  South Africa Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.8.  Turkey

6.7.8.1.  Turkey Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

6.7.9.  Rest of Middle East and Africa

6.7.9.1.  Rest of Middle East and Africa Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

7.       Company Profiles

7.1.     BioLight Technologies LLC

7.1.1.  Business Overview

7.1.2.   Service Portfolio

7.1.3.  Strategic Developments

7.1.4.  Financial Overview

7.2.     THOR

7.2.1.  Business Overview

7.2.2.   Service Portfolio

7.2.3.  Strategic Developments

7.2.4.  Financial Overview

7.3.     LumiThera

7.3.1.  Business Overview

7.3.2.   Service Portfolio

7.3.3.  Strategic Developments

7.3.4.  Financial Overview

7.4.     Vielight Inc.

7.4.1.  Business Overview

7.4.2.   Service Portfolio

7.4.3.  Strategic Developments

7.4.4.  Financial Overview

7.5.     Aspen Laser Systems, LLC,

7.5.1.  Business Overview

7.5.2.   Service Portfolio

7.5.3.  Strategic Developments

7.5.4.  Financial Overview

7.6.     Theralase Inc

7.6.1.  Business Overview

7.6.2.   Service Portfolio

7.6.3.  Strategic Developments

7.6.4.  Financial Overview

7.7.     Apira Science Inc.

7.7.1.  Business Overview

7.7.2.   Service Portfolio

7.7.3.  Strategic Developments

7.7.4.  Financial Overview

7.8.     IRRADIA AUSTRALIA

7.8.1.  Business Overview

7.8.2.   Service Portfolio

7.8.3.  Strategic Developments

7.8.4.  Financial Overview

7.9.     Good Health Tech.

7.9.1.  Business Overview

7.9.2.   Service Portfolio

7.9.3.  Strategic Developments

7.9.4.  Financial Overview

7.10. Omega Laser Systems Ltd

7.10.1.      Business Overview

7.10.2.       Service Portfolio

7.10.3.      Strategic Developments

7.10.4.      Financial Overview

8.       Photobiomodulation Therapy Market Forecast (2017-2027)

8.1.     Global Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2027)

8.2.     Photobiomodulation Therapy Market Forecast by Regions (2017-2027)

8.2.1.  North America Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.1.1.  United States Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.1.2.  Canada Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.1.3.  Mexico Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.2.  Europe Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.2.1.  Germany Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.2.2.  France Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.2.3.  UK Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.2.4.  Russia Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.2.5.  Italy Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.2.6.  Rest of Europe Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.3.  Asia-Pacific Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.3.1.  China Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.3.2.  Japan Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.3.3.  Korea Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.3.4.  India Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.3.5.  Southeast Asia Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.3.6.  Rest of Asia-Pacific Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.4.  South America Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.4.1.  Brazil Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.4.2.  Argentina Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.4.3.  Columbia Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.4.4.  Rest of South America Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.5.  Middle East and Africa Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.5.1.  Saudi Arabia Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.5.2.  United Arab Emirates Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.5.3.  Egypt Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.5.4.  Nigeria Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.5.5.  South Africa Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.5.6.  Turkey Photobiomodulation Therapy Market Forecast (2017-2027)

8.2.5.7.  Rest of Middle East and Africa Photobiomodulation Therapy Market Forecast (2017-2027)

8.3.     Photobiomodulation Therapy Market Forecast by Application (2017-2027)

8.3.1.  Photobiomodulation Therapy Forecast by Application (2017-2027)

8.3.2.  Photobiomodulation Therapy Market Share Forecast by Application (2017-2027)


List of Tables

List of Tables and Figures:

Figure United States Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Photobiomodulation Therapy Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Photobiomodulation Therapy Revenue and Revenue Share by Application (2017-2018)
Figure Global Pain Management Revenue and Growth Rate (2017-2018)
Figure Global Musculoskeletal Revenue and Growth Rate (2017-2018)
Figure Global Arthritis Revenue and Growth Rate (2017-2018)
Figure Global Wound Healing Revenue and Growth Rate (2017-2018)
Figure Global Dermatology Revenue and Growth Rate (2017-2018)
Figure Global Nerve Regeneration Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Photobiomodulation Therapy Revenue by Regions (2017-2018)
Figure North America Photobiomodulation Therapy Growth Rate (2017-2018)
Figure North America Photobiomodulation Therapy Revenue and Growth Rate (2017-2018)
Figure North America Photobiomodulation Therapy by Countries (2017-2018)
Figure North America Photobiomodulation Therapy Revenue (Million USD) by Countries (2017-2018)
Figure United States Photobiomodulation Therapy Growth Rate (2017-2018)
Figure United States Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Canada Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Mexico Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Europe Photobiomodulation Therapy Revenue and Growth Rate (2017-2018)
Figure Europe Photobiomodulation Therapy by Countries (2017-2018)
Figure Europe Photobiomodulation Therapy Revenue (Million USD) by Countries (2017-2018)
Figure Germany Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Germany Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Photobiomodulation Therapy Growth Rate (2017-2018)
Figure France Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Photobiomodulation Therapy Growth Rate (2017-2018)
Figure UK Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Russia Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Italy Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Rest of Europe Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Asia-Pacific Photobiomodulation Therapy Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Photobiomodulation Therapy by Countries (2017-2018)
Figure Asia-Pacific Photobiomodulation Therapy Revenue (Million USD) by Countries (2017-2018)
Figure China Photobiomodulation Therapy Growth Rate (2017-2018)
Figure China Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Japan Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Korea Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Photobiomodulation Therapy Growth Rate (2017-2018)
Figure India Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Southeast Asia Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Photobiomodulation Therapy Growth Rate (2017-2018)
Figure South America Photobiomodulation Therapy Revenue and Growth Rate (2017-2018)
Figure South America Photobiomodulation Therapy by Countries (2017-2018)
Figure South America Photobiomodulation Therapy Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Brazil Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Argentina Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Columbia Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Rest of South America Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Middle East and Africa Photobiomodulation Therapy Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Photobiomodulation Therapy by Countries (2017-2018)
Figure Middle East and Africa Photobiomodulation Therapy Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Saudi Arabia Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Photobiomodulation Therapy Growth Rate (2017-2018)
Figure United Arab Emirates Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Egypt Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Nigeria Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Photobiomodulation Therapy Growth Rate (2017-2018)
Figure South Africa Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Turkey Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Photobiomodulation Therapy Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2017-2018)
Table BioLight Technologies LLC Photobiomodulation Therapy Financial Overview
Table THOR Photobiomodulation Therapy Financial Overview
Table LumiThera Photobiomodulation Therapy Financial Overview
Table Vielight Inc. Photobiomodulation Therapy Financial Overview
Table Aspen Laser Systems, LLC, Photobiomodulation Therapy Financial Overview
Table Theralase Inc Photobiomodulation Therapy Financial Overview
Table Apira Science Inc. Photobiomodulation Therapy Financial Overview
Table IRRADIA AUSTRALIA Photobiomodulation Therapy Financial Overview
Table Good Health Tech. Photobiomodulation Therapy Financial Overview
Table Omega Laser Systems Ltd Photobiomodulation Therapy Financial Overview
Figure Global Photobiomodulation Therapy Revenue (Millions USD) and Growth Rate (2018-2025)
Table Photobiomodulation Therapy Market Forecast by Regions (2018-2025)
Figure North America Photobiomodulation Therapy Market Forecast (2018-2025)
Figure United States Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Canada Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Mexico Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Europe Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Germany Photobiomodulation Therapy Market Forecast (2018-2025)
Figure France Photobiomodulation Therapy Market Forecast (2018-2025)
Figure UK Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Russia Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Italy Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Rest of Europe Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Asia-Pacific Photobiomodulation Therapy Market Forecast (2018-2025)
Figure China Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Japan Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Korea Photobiomodulation Therapy Market Forecast (2018-2025)
Figure India Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Southeast Asia Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Photobiomodulation Therapy Market Forecast (2018-2025)
Figure South America Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Brazil Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Argentina Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Columbia Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Rest of South America Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Middle East and Africa Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Saudi Arabia Photobiomodulation Therapy Market Forecast (2018-2025)
Figure United Arab Emirates Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Egypt Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Nigeria Photobiomodulation Therapy Market Forecast (2018-2025)
Figure South Africa Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Turkey Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Photobiomodulation Therapy Market Forecast (2018-2025)
Figure Global Photobiomodulation Therapy Forecast by Application (2018-2025)
Figure Global Photobiomodulation Therapy Market Share Forecast by Application (2018-2025)
Figure Global Photobiomodulation Therapy Forecast by Application (2018-2025)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*